Abstract
In myocardial infarction, a blockage in one of the coronary arteries leads to ischemic conditions in the left ventricle of the myocardium and, therefore, to significant death of contractile cardiac cells. This process leads to the formation of scar tissue, which reduces heart functionality. Cardiac tissue engineering is an interdisciplinary technology that treats the injured myocardium and improves its functionality. However, in many cases, mainly when employing injectable hydrogels, the treatment may be partial because it does not fully cover the diseased area and, therefore, may not be effective and even cause conduction disorders. Here, we report a hybrid nanocomposite material composed of gold nanoparticles and an extracellular matrix-based hydrogel. Such a hybrid hydrogel could support cardiac cell growth and promote cardiac tissue assembly. After injection of the hybrid material into the diseased area of the heart, it could be efficiently imaged by magnetic resonance imaging (MRI). Furthermore, as the scar tissue could also be detected by MRI, a distinction between the diseased area and the treatment could be made, providing information about the ability of the hydrogel to cover the scar. We envision that such a nanocomposite hydrogel may improve the accuracy of tissue engineering treatment.
Original language | English |
---|---|
Article number | 1298 |
Journal | Pharmaceutics |
Volume | 15 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2023 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2023 by the authors.
Funding
M.S. thanks the Ministry of Science, Technology, and Space, Israel, for the Ze’ev Jabotinsky fellowship. T.D. received support from ERC Starting Grant No. 637943, ERC Consolidator Grant 101001242, the Slezak Foundation, the Israeli Science Foundation (700/13), the Moxie Foundation and the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel. T.D. is the Closner Family Chair for Next-Generation Organ and Tissue Implants.
Funders | Funder number |
---|---|
Slezak Foundation | |
Moxie Foundation | |
European Commission | 637943, 101001242 |
Ministry of Science, Technology and Space | |
United States-Israel Binational Science Foundation | |
Israel Science Foundation | 700/13 |
Keywords
- ECM-based hydrogel
- MRI
- gadolinium
- gold nanoparticles
- myocardial infarction
- tissue engineering